FDA Drug Application (022200) for BYDUREON by ASTRAZENECA AB

Back to FDA Applications sponsored by ASTRAZENECA AB

Application Number022200
Product Number001
FormFOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS
Dosage2MG/VIAL
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameBYDUREON
Active IngredientEXENATIDE SYNTHETIC

Active IngredientCount
List of drugs with Active Ingredient EXENATIDE SYNTHETIC3


Back to FDA Applications sponsored by ASTRAZENECA AB